PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacology, Amiens University Hospital, Amiens, France.\', \'MP3CV Laboratory, EA7517, Jules Verne University of Picardie, Amiens, France.\', \'Department of Virology, Amiens University Medical Center, Amiens, France.\', \'EA 4294, Jules Verne University of Picardie, Amiens, France.\', \'Infectious Diseases Department, University Hospital, Amiens, France.\', \'Department of Pneumology, University Hospital of Amiens-Picardie, Amiens, France.\', \'Epidemiology and Public Health Service, Amiens University Hospital, Amiens, France.\', \'Intensive Care Department and BoReal study group, Amiens University Hospital, Amiens, France.\', \'Department of Anesthesiology and Critical Care Medicine, Amiens University Medical Center, Amiens, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ehjcvp/pvaa062
?:doi
?:hasPublicationType
?:journal
  • European heart journal. Cardiovascular pharmacotherapy
is ?:pmid of
?:pmid
?:pmid
  • 32531040
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Association between renin-angiotensin system inhibitors and COVID-19 complications.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all